48,453
edits
Difference between revisions of "Squamous cell carcinoma"
Jump to navigation
Jump to search
Squamous cell carcinoma (view source)
Revision as of 18:21, 21 September 2020
, 18:21, 21 September 2020→See also
| (4 intermediate revisions by the same user not shown) | |||
| Line 149: | Line 149: | ||
==Spindle cell squamous carcinoma== | ==Spindle cell squamous carcinoma== | ||
*[[AKA]] ''sarcomatoid squamous cell carcinoma''.<ref name=pmid18787630 >{{Cite journal | last1 = Hall | first1 = JM. | last2 = Saenger | first2 = JS. | last3 = Fadare | first3 = O. | title = Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas. | journal = Int J Clin Exp Pathol | volume = 1 | issue = 6 | pages = 524-30 | month = Mar | year = 2008 | doi = | PMID = 18787630 }}</ref> | |||
===General=== | ===General=== | ||
*Common spindle cell lesion of the head and neck. | *Common spindle cell lesion of the head and neck. | ||
| Line 227: | Line 228: | ||
*[[p63]] +ve. | *[[p63]] +ve. | ||
*K903 +ve. | *K903 +ve. | ||
*p16 +ve/-ve -- dependent on site, +ve favours non-lung SCC.<ref name=pmid20823766/> | *[[p16]] +ve/-ve -- dependent on site, +ve favours non-lung SCC.<ref name=pmid20823766/> | ||
*[[p40]] +ve. | |||
Note: | |||
*Immunostains not particularly helpful for establishing primary site of squamous cell carcinoma. p16 may be helpful but is not definitive for non-lung SCC.<ref name=pmid20823766/> | |||
=See also= | =See also= | ||
*[[Adenocarcinoma]]. | *[[Adenocarcinoma]]. | ||
*[[Pseudoepitheliomatous hyperplasia]] - can mimic squamous cell carcinoma. | |||
*[[Basics]]. | *[[Basics]]. | ||